New Chief of Bone Marrow Transplant and Cellular Therapies Named
Following an extensive national search, Ira Braunschweig, MD, has been named chief, Section of Transplant and Cell Therapy at Rutgers Cancer Institute, chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line, and director for Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. Dr. Braunschweig will lead the Blood and Marrow Transplant and Cellular Therapies Program at Rutgers Cancer Institute when he arrives early June. In his roles, he will oversee the clinical and research activities within the program and will also collaborate with colleagues across RWJBarnabas Health on clinical research activities in bone marrow transplantation. Learn more
$3.5 Million NIH Grant Will Support a new ‘Lens’ in Lung Cancer Screening
With the aid of a $3.5 million National Institutes of Health grant (R01HL158850), investigators from Rutgers Cancer Institute of New Jersey along with Holden Cancer Center at the University of Iowa, and the University of Texas MD Anderson Cancer Center, are collaborating on a project to address lung cancer screening disparities among individuals with a history of heavy smoking. The study is led by principal investigator Anita Kinney, PhD, director of the Cancer Health Equity Center of Excellence at Rutgers Cancer Institute and Rutgers School of Public Health. Learn more
Rutgers Cancer Institute of New Jersey Receives Patient Lodging and Transportation Awards from the American Cancer Society
The American Cancer Society has awarded Rutgers Cancer Institute of New Jersey several patient transportation and lodging grants. Cancer patients undergoing treatment frequently require assistance getting to and from facilities, often adding stressful financial and logistical burdens on top of their diagnosis. The grants will help alleviate the financial burden of transportation and lodging costs for patients at Rutgers Cancer Institute. Learn more
Rutgers Cancer Institute of New Jersey Nurses Present Findings at the 47th Annual Oncology Nursing Society Congress
Oncology Nurses from Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health recently presented at the Oncology Nursing Society’s (ONS) 47th Annual Congress in Anaheim, California. As an academic medical center and an NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute nurses are provided with an opportunity to participate in local, national and international meetings throughout the year. The importance of OCN (Oncology Certified Nurse) certification, simplified weekly education for nursing teams, and handling techniques of the therapy option known as mitomycin gel were among the research topics presented. Learn more
May is National Cancer Research Month
To highlight the importance of lifesaving cancer research, National Cancer Research Month, led by the American Association for Cancer Research, is recognized during the month of May. Rutgers Cancer Institute of New Jersey prevails as the state’s only National Cancer Institute-designated Comprehensive Cancer Center, together with RWJBarnabas Health, to address the cancer research demands of one of the most diverse and densely populated states in the nation. View 2022 research news and highlights From Rutgers Cancer Institute. Read more
As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.